Hematopoietic Engraftment in Recipients of Unrelated Donor Umbilical Cord Blood Is Affected by the CD34+ and CD8+ Cell Doses

Biology of Blood and Marrow Transplantation

Volumn 13, Issue 7, 2007, Pages 822-830

  Terakura, Seitaro ^a,f   Azuma, Eiichi ^b,f   Murata, Makoto ^a,f   Kumamoto, Tadashi ^b,f   Hirayama, Masahiro ^b,f   Atsuta, Yoshiko ^c,f   Kodera, Yoshihisa ^d,f   Yazaki, Makoto ^e,f   Naoe, Tomoki ^a,f   Kato, Koji ^d,f  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^e Nagoya Higashi Health Center   (Japan)

^f Tokai Cord Blood Bank   (Japan)

Author keywords

CD34; CD8; Cord blood transplantation; Engraftment; T lymphocyte

Indexed keywords

CYCLOSPORIN A; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; APLASTIC ANEMIA; ARTICLE; CD34 SELECTION; CD4+ T LYMPHOCYTE; CHILD; CHRONIC MYELOID LEUKEMIA; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DONOR; ENGRAFTMENT; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INBORN ERROR OF METABOLISM; INCIDENCE; INFANT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; NONHODGKIN LYMPHOMA; RECIPIENT; SOLID TUMOR; T CELL LEUKEMIA; T CELL LYMPHOMA;

ADOLESCENT; ADULT; AGED; ANEMIA, APLASTIC; ANTIGENS, CD34; ANTIGENS, CD8; ANTIGENS, DIFFERENTIATION; CHILD; CHILD, PRESCHOOL; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELLS; HUMANS; INFANT; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; SEVERE COMBINED IMMUNODEFICIENCY;

EID: 34250196843     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2007.03.006     Document Type: Article

References (42)

1. Kurzberg J., Laughlin M., Graham M.L., et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated donors. N Engl J Med 335 (1996) 157-166
2. Wagner J.E., Rosenthal J., Sweetman R., et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 88 (1996) 795-802
3. Gluckman E., Rocha V., Boyer-Chammard A., et al. Outcome of cord-blood transplantation from related and unrelated donors: Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 337 (1997) 373-381
4. Rubinstein P., Carrier C., Stevens C.E., et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 339 (1998) 1565-1577
5. Laughlin M.J., Eapen M., Rubinstein P., et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 351 (2004) 2265-2275
6. Rocha V., Labopin M., Sanz G., et al., Acute Leukemia Working Party of European Blood and Marrow Transplantation Group, Eurocord-Netcord Registry. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 351 (2004) 2276-2285
7. Takahashi S., Iseki T., Asano S., et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood 104 (2004) 3813-3820
8. Barker J.N., and Wagner J.E. Umbilical cord blood transplantation: current state of the art. Curr Opin Oncol 14 (2002) 160-164
9. Rocha V., and Gluckman E. Clinical use of umbilical cord blood hematopoietic stem cells. Biol Blood Marrow Transplant 12 (2006) 34-41
10. Barker J.N., Krepski T.P., Weisdorf D.J., et al. Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 8 (2002) 257-260
11. Laughlin M.J., Barker J.N., Bambach B., et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 344 (2001) 1815-1822
12. Gluckman E., Rocha V., Chevret S., et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 32 (2004) 397-407
13. Wagner J.E., Barker J.N., Davies S.M., et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100 (2002) 1611-1618
14. Sanz M.A., and Sanz G.F. Unrelated donor umbilical cord blood transplantation in adults. Leukemia 16 (2002) 1984-1991
15. Kernan N.A., Flomenberg N., O'Reilly R.J., et al. Graft rejection in recipients of T cell depleted HLA-nonidentical marrow transplants for leukemia: identification of host derived anti-donor allocytotoxic T lymphocytes. Transplantation 43 (1987) 482-487
16. Martin P.J., Hansen J.A., Buckner C.D., et al. Effect of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 66 (1985) 664-672
17. + T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation. Blood 76 (1990) 418-423
18. Martin P.J., Rowley S.D., Anasetti C., et al. A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients. Blood 94 (1999) 2192-2199
19. Ildstad S.T., Wren S.M., Bluestone J.A., Barbieri S.A., Stephany D., and Sachs D.H. Effect of selective T-cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft versus host disease in mixed allogeneic chimeras (B10 + B10.D2 → B10). J Immunol 136 (1986) 28-33
20. Martin P.J. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans. J Exp Med 178 (1993) 703-712
21. Sutherland D.R., Anderson L., and Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry: International Society of Hematoherapy and Graft Engineering. J Hematother 5 (1996) 213-226
22. Centers for Disease Control and Prevention. 1997 Revised guidelines for performing CD4+ T-cell determinations in persons infected with human immunodeficiency virus (HIV). MMWR Recomm Rep 46 (1997) 1-29
23. Kobayashi M., Azuma E., Ido M., et al. A pivotal role of Rho GTPase in the regulation of morphology and function of dendritic cells. J Immunol 167 (2001) 3585-3591
24. Przepiorka D., Weisdorf D., Thomas E.D., et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 15 (1995) 825-828
25. Sullivan K.M., Shulman H.M., Thomas E.D., et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 57 (1981) 267-276
26. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. Am Stat Assoc J 53 (1958) 457-481
27. Gooley T.A., Leisenring W., Crowley J.A., and Storer B.E. Estimation of failure probability in the presence of competing risks: new representations of old estimators. Stat Med 18 (1999) 665-706
28. Cox D.R. Regression models and life-tables. J R Stat Soc B 34 (1972) 187-202
29. Sanz G.F., Saavedra S., Planelles D., et al. Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood 98 (2001) 2332-2338
30. Martin P.J. Winning the battle of graft versus host. Nat Med 6 (2000) 18-19
31. Martin P.J., Akatsuka Y., Hahne M., and Sale G. Involvement of donor T-cell cytotoxic effector mechanisms in preventing allogeneic marrow graft rejection. Blood 92 (1998) 2177-2181
32. Kaufman C.L., Colson Y.L., Wren S.M., Watkins S., Simmons R.L., and Ildstad S.T. Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 84 (1994) 2436-2446
33. Gandy K.L., Domen J., Aguila H., and Weissman I.L. CD8+TCR+ and CD8+TCR-cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers. Immunity 11 (1999) 579-590
34. Miller R.G. An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing it. Nature 287 (1980) 544-546
35. Reich-Zeliger S., Zhao Y., Krauthgamer R., Bachar-Lustig E., and Reisner Y. Anti-third party CD8+ CTLs as potent veto cells: coexpression of CD8 and FasL is a prerequisite. Immunity 13 (2000) 507-515
36. Fink P.J., Shimonkevitz R.P., and Bevan M.J. Veto cells. Annu Rev Immunol 6 (1988) 115-137
37. Bachar-Lustig E., Reich-Zeliger S., and Reisner Y. Anti-third-party veto CTLs overcome rejection of hematopoietic allografts: synergism with rapamycin and BM cell dose. Blood 102 (2003) 1943-1950
38. Cohen S.B., Perez-Cruz I., Fallen P., Gluckman E., and Madrigal J.A. Analysis of the cytokine production by cord and adult blood. Hum Immunol 60 (1999) 331-336
39. Narimatsu H., Terakura S., Matsuo K., et al. Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults. Bone Marrow Transplant 39 (2007) 31-39
40. Locatelli F., Rocha V., Reed W., et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 101 (2003) 2137-2143
41. Ruggeri L., Capanni M., Velardi A., et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295 (2002) 2097-2100
42. Farag S.S., Fehniger T.A., Caligiuri M.A., et al. Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. Blood 100 (2002) 1935-1947